Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
28.00
+1.00 (3.70%)
At close: Mar 31, 2025
5.26%
Market Cap 68.78M
Revenue (ttm) 110.94M
Net Income (ttm) 4.57M
Shares Out 2.46M
EPS (ttm) 1.86
PE Ratio 15.06
Forward PE n/a
Dividend 0.50 (1.79%)
Ex-Dividend Date Sep 12, 2024
Volume 8
Average Volume 60
Open 25.60
Previous Close 27.00
Day's Range 25.60 - 28.00
52-Week Range 16.20 - 32.60
Beta 0.91
RSI 52.52
Earnings Date May 12, 2025

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 222
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2024, Biogened's revenue was 110.94 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 4.57 million, a decrease of -10.38%.

Financial Statements

News

There is no news available yet.